$6.360
-0.020 (-0.31%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
EBS Prediction & Forecast by Similar Chart Analysis
Alphio's EBS stock price prediction model matches the current Emergent BioSolutions Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $6.38 (+1.38%). The 1-week path is $6.40 (+1.76%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Emergent BioSolutions Inc Stock?
Emergent BioSolutions Inc is not a good buy right now due to significant financial losses and bearish market sentiment. The current price is $6.38, and the company reported a staggering net loss of $180.2 million in Q2 2026, which has led to a year-to-date decline of 49%. Furthermore, insider selling has increased by 140.86%, indicating a lack of confidence from those closest to the company.
EBS stock price ended at $6.36 on Monday, after losing -0.31%
Emergent BioSolutions Inc (EBS) last closed at $6.29, losing -1.10%. These facts feed the 1-day and 1-week EBS price prediction above.
Analyst Consensus
Emergent BioSolutions Inc (EBS): 5 buy, 1 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Emergent BioSolutions Inc (EBS) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches EBS, ranked by similarity.
Seasonality analysis for EBS
Historically the probability of a positive October return for EBS is 41.67%. December offers the highest probability of a positive month at 100.00%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for EBS
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $6.63 | $7.63 | $9.10 | +21.33% |
| Nov 2026 | $4.09 | $6.02 | $8.10 | -4.33% |
| Dec 2026 | $4.14 | $6.42 | $7.49 | +2.10% |
In 2026, Emergent BioSolutions Inc (EBS) is projected to range from $4.09 to $9.10.
Emergent BioSolutions Inc 2026 monthly forecast
In Oct 2026, Emergent BioSolutions Inc is projected to average $7.63, with a low of $6.63 and high of $9.10.
In Nov 2026, Emergent BioSolutions Inc is projected to average $6.02, with a low of $4.09 and high of $8.10.
In Dec 2026, Emergent BioSolutions Inc is projected to average $6.42, with a low of $4.14 and high of $7.49.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.